The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
aTyr Pharma, Inc(NASDAQ:LIFE) 
aTyr Pharma, Inc., a clinical stage biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead clinical product candidate is ATYR1923, a selective modulator of NRP2 for the treatment of patients with s...
Website: http://www.atyrpharma.com
Founded: 2005
Full Time Employees: 39
Sector: Healthcare
Industry: Biotechnology
aTyr Pharma Days Payable Outstanding ttm (DPO)
aTyr Pharma Days Receivable Outstanding ttm (DSO)
aTyr Pharma Days Inventory Outstanding ttm (DIO)
aTyr Pharma Op Cashflow Per Share ttm
aTyr Pharma Free Cashflow Per Share ttm
aTyr Pharma Cash Per Share ttm
aTyr Pharma P/S ratio ttm
aTyr Pharma (GAAP) P/E ratio ttm
aTyr Pharma P/B ratio ttm
No extra charts and metrics for this ticker.